Santa Barbara houses the Center for the Study of Macular Degeneration, a biomedical research unit dedicated to the research int cellular, molecular and genetic factors that contribute to macular degeneration. The research center encourages interactions between basic and clinical scientists in an attempt to create a foundation for the development of both diagnostic and therapeutic approaches to treating macular degeneration.
The Center for the Study of Macular Degeneration (CSMD) has undertaken several research initiatives, examining many of the elements associated with age-related macular degeneration.
The Santa Barbara research facility is concentrating on one area of study involves drusen. While it has not been proven that drusen causes macular degeneration, the eye disease is rarely diagnosed in its absence. Research into how drusen form and the nature of the relationship between druse and the pathogenesis of macular degeneration should be discovered.
Scientists at the Santa Barbara CSMD have published the protein composition of drusen and have been researching using gene expression to identify the specific cell types that may be responsible for creating the proteins found in drusen. This may lead to the understanding how drusen is formed in patients diagnosed with macular degeneration and eventually lead to new treatments for macular degeneration.
Other research is being conducted in early cellular events that may be involved in the creation of drusen.
The CSMD has also published articles on genes related to age-related macular degeneration, and evidence for an inflammatory process in age-related macular degeneration.
The Center for the Study of Macular Degeneration in Santa Barbara, a world class research facility advancing the cause for those people suffering from the eye disease, macular degeneration.